Driven by Innovation & Growth
Our mission is to promote innovation and growth through strengthened networks; advocacy; capital investment; talent attraction, development and retention; and advancing the next generation of leaders.
Virginia's Life Science Community By the Numbers
-
3,433 Companies
Life science companies in Virginia.
-
$8B Industry
Life Science contributes $8B to Virginia's economy.
-
30, 504 People
Employed by Life Science companies in Virginia.
-
$107,281 Average Wage
Average earnings of life science workers in Virginia.
-
1,197 Clinical trials
Biopharmaceutical industry-sponsored trials in Virginia per year.
News
08/22/2025
ivWatch Technology Linked to Major Reduction in Severe IV Injuries in Newborns Over Four-Year Study
A study published this month in The BMJ (British Medical Journal) analyzed the use of optical sensor technology from ivWatch, the U.S.-based IV safety company, in the early detection of peripheral intravenous infiltration or extravasation (PIVIE) events in neonates. Presenting a comparative evaluation between conventional observational methods and continuous sensor-based monitoring, the study offers insights …
08/21/2025
ReAlta Life Sciences Receives EMA Orphan Drug Designation for RLS-0071 (pegtarazimod) for the Treatment of Graft-Versus-Host Disease
ReAlta Life Sciences, Inc. (“ReAlta” or the “Company”), a clinical-stage biopharmaceutical company dedicated to saving lives by rebalancing the inflammatory response to address rare and acute inflammatory diseases, today announced that the European Medicines Agency (EMA) has granted Orphan Drug Designation to RLS-0071 (pegtarazimod) for the treatment of Graft-versus-Host Disease (GvHD). The Orphan Drug Designation …
08/20/2025
LifeNet Health Acquires HCM Medical to Meet Surging Global Demand for Regenerative Biologics and Advanced Therapeutics
In a transformative move to accelerate global access to life-restoring technologies, LifeNet Health, a world leader in regenerative medicine, has acquired HCM Medical, a Netherlands-based contract manufacturing organization (CMO) known for its pioneering biologics and tissue-processing capabilities. This strategic acquisition addresses a critical challenge in modern healthcare: ensuring timely, equitable access to breakthrough regenerative therapies for …